The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma …

Published December 13, 2012

The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma …
Filed under: dual diagnosis treatment program

“The data presented at ASH span research programs with the most incredible potential for next-generation treatments for this devastating disease, and demonstrate the incredible power that innovative partnerships can have in advancing research,” stated …
{Source}

John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual …
Filed under: dual diagnosis treatment program

"John Theurer Cancer Center's early drug discovery program is part of many of the exciting developments at this year's ASH, including second generation proteasome inhibitors, such as oprozomib and lenalidomide, and other emerging agents, such as …
{Source}